Skip to content

Mosaic ImmunoEngineering Inc.

CPMV · OTCM

CIK 836564fmd_0EPE51DXAYGBA6W5NP9YWD6P7MManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Dec 01, 2009 to Jun 30, 2026, 67 periods

Latest annual · FY2025

Millions
Operating income
(1)
Net income
(1)

Latest quarter · Q2 FY2026

Millions
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2020 to FY2025
n/m

Mosaic ImmunoEngineering Inc. (CPMV) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Operating income-$616,119-$879,65510-K 2026-04-15 · proof
Net income-$687,846-$921,98310-K 2026-04-15 · proof
Cash from operating activities-$111,397-$241,15910-K 2026-04-15 · proof
Total assets$19,882$141,611-86%10-K 2026-04-15 · proof
Total liabilities$7.5 million$6.9 million+8.2%10-K 2026-04-15 · proof
Cash and cash equivalents$3,622$115,019-96.9%10-K 2026-04-15 · proof
What was Mosaic ImmunoEngineering Inc. (CPMV)'s operating income in fiscal 2025?
Mosaic ImmunoEngineering Inc. (CPMV) reported operating income of -$616,119 for fiscal 2025 (the year ended Dec 31, 2025), against -$879,655 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
What was Mosaic ImmunoEngineering Inc. (CPMV)'s net income in fiscal 2025?
Mosaic ImmunoEngineering Inc. (CPMV) reported net income of -$687,846 for fiscal 2025 (the year ended Dec 31, 2025), against -$921,983 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
What was Mosaic ImmunoEngineering Inc. (CPMV)'s cash from operating activities in fiscal 2025?
Mosaic ImmunoEngineering Inc. (CPMV) reported cash from operating activities of -$111,397 for fiscal 2025 (the year ended Dec 31, 2025), against -$241,159 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
What are Mosaic ImmunoEngineering Inc. (CPMV)'s total assets?
As of Dec 31, 2025, Mosaic ImmunoEngineering Inc. (CPMV) reported total assets of $19,882, against $141,611 a year earlier (-86%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
What are Mosaic ImmunoEngineering Inc. (CPMV)'s total liabilities?
As of Dec 31, 2025, Mosaic ImmunoEngineering Inc. (CPMV) reported total liabilities of $7.5 million, against $6.9 million a year earlier (+8.2%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
What are Mosaic ImmunoEngineering Inc. (CPMV)'s cash and cash equivalents?
As of Dec 31, 2025, Mosaic ImmunoEngineering Inc. (CPMV) reported cash and cash equivalents of $3,622, against $115,019 a year earlier (-96.9%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CPMV&period_type=annual&limit=5"

Information only, not investment advice.